References
- Bright, R. A., D. K. Shay, B. Shu, N. J. Cox, and A. I. Klimov. 2006. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 295: 891-894. https://doi.org/10.1001/jama.295.8.joc60020
- Cassetti, M. C., R. Couch, J. Wood, and Y. Pervikov. 2005. Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004. Vaccine 23: 1529-1533. https://doi.org/10.1016/j.vaccine.2004.09.004
- CDC. 2009. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. Morb. Mortal. Wkly. Rep. 58.
- Choi, H. J., J. H. Song, K. S. Park, and D. H. Kwon. 2009. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur. J. Pharm. Sci. 37: 329-333. https://doi.org/10.1016/j.ejps.2009.03.002
- Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162: 156-159.
- Condit, R. C. 2006. Fields virology, pp. 25-57. In D. M. Knipe and P. M. Howley (eds.). Principles of Virology, 5th Ed. Lippincott Williams and Wilkins, Philadelphia.
- Couch, R. B. and G. G. Jackson. 1976. Antiviral agents in influenza - summary of Influenza Workshop VIII. J. Infect. Dis. 134: 516-527. https://doi.org/10.1093/infdis/134.5.516
- De Clercq, E. 2004. Antiviral drugs in current clinical use. J. Clin. Virol. 30: 115-133. https://doi.org/10.1016/j.jcv.2004.02.009
- Furuta, Y., K. Takahashi, M. Kuno-Maekawa, H. Sangawa, S. Uehara, K. Kozaki, et al. 2005. Mechanism of action of T-705 against influenza virus. Antimicrob. Agents Chemother. 49: 981-986. https://doi.org/10.1128/AAC.49.3.981-986.2005
- Garten, R. J., C. T. Davis, C. A. Russell, B. Shu, S. Lindstrom, A. Balish, et al. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201. https://doi.org/10.1126/science.1176225
- Glezen, W. P. 1996. Emerging infections: Pandemic influenza. Epidemiol. Rev. 18: 64-76. https://doi.org/10.1093/oxfordjournals.epirev.a017917
- Hampson, A. W. 2002. Influenza virus antigens and 'antigenic drift', pp. 49-85. In C. W. Potter (ed.). Perspectives in Medical Virology, Vol. 7. Elsevier.
- Hui, E. K. and D. P. Nayak. 2001. Role of ATP in influenza virus budding. Virology 290: 329-341. https://doi.org/10.1006/viro.2001.1181
- Irvine, J. D., L. Takahashi, K. Lockhart, J. Cheong, J. W. Tolan, H. E. Selick, and J. R. Grove. 1999. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm. Sci. 88: 28-33. https://doi.org/10.1021/js9803205
- Jackson, D. C. and L. E. Brown. 1991. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen. Pept. Res. 4: 114-124.
- Kawaoka, Y. 2006. Influenza Virology: Current Topics. Caister Academic Press.
- Kelly, H. and K. Grant. 2009. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: Surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro. Surveill. 14.
- Kiso, M., K. Takahashi, Y. Sakai-Tagawa, K. Shinya, S. Sakabe, Q. M. Le, et al. 2010. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc. Natl. Acad. Sci. USA 107: 882-887. https://doi.org/10.1073/pnas.0909603107
- Murris-Espin, M., A. Didier, S. Mezghani, L. Lacassagne, and P. Leophonte. 1999. Influenza and asthma. Rev. Mal. Res. 16: 9-15.
- Noah, J. W., W. Severson, D. L. Noah, L. Rasmussen, E. L. White, and C. B. Jonsson. 2007. A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res. 73: 50-59. https://doi.org/10.1016/j.antiviral.2006.07.006
- Numazaki, Y., T. Oshima, A. Ohmi, A. Tanaka, Y. Oizumi, S. Komatsu, et al. 1987. A microplate method for isolation of viruses from infants and children with acute respiratory infections. Microbiol. Immunol. 31: 1085-1095. https://doi.org/10.1111/j.1348-0421.1987.tb01340.x
- Palese, S. M. 2007. Orthomyxoviridae: The viruses and their replication, pp. 1647-1689. In K. DM and H. PM (eds.). Fields Virology, 5th Ed. Lippincott Williams &Wilkins, Philadelphia.
- Poland, G. A., R. M. Jacobson, and P. V. Targonski. 2007. Avian and pandemic influenza: An overview. Vaccine 25: 3057-3061. https://doi.org/10.1016/j.vaccine.2007.01.050
- Renaud, C., J. Kuypers, and J. A. Englund. 2011. Emerging oseltamivir resistance in seasonal and pandemic influenza A/ H1N1. J. Clin. Virol. 52: 70-78. https://doi.org/10.1016/j.jcv.2011.05.019
- WHO. 2009. Summary report of a high-level consultation: New influenza A (H1N1). World Health Organization, Geneva.
Cited by
- Low-Volatile Lipophilic Compounds in Needles, Defoliated Twigs, and Outer Bark of Pinus thunbergii vol.8, pp.12, 2013, https://doi.org/10.1177/1934578x1300801227
- Anti-Diabetic Effect ofAster sphathulifoliusin C57BL/KsJ-db/dbMice vol.18, pp.9, 2013, https://doi.org/10.1089/jmf.2014.3416
- Thuja orientalis reduces airway inflammation in ovalbumin-induced allergic asthma vol.12, pp.3, 2013, https://doi.org/10.3892/mmr.2015.3910
- Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats vol.19, pp.4, 2013, https://doi.org/10.1089/jmf.2015.3566
- In Vitro Antiviral Activity of Cinnamomum cassia and Its Nanoparticles Against H7N3 Influenza A Virus vol.26, pp.1, 2013, https://doi.org/10.4014/jmb.1508.08024
- Inhibitory effects of Aster spathulifolius extract on adipogenesis and lipid accumulation in 3T3‐L1 preadipocytes vol.68, pp.1, 2016, https://doi.org/10.1111/jphp.12485
- Anti‐melanogenic effects of Aster spathulifolius extract in UVB‐exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling vol.68, pp.4, 2013, https://doi.org/10.1111/jphp.12524
- Germacrone Attenuates Hyperlipidemia and Improves Lipid Metabolism in High-Fat Diet-Induced Obese C57BL/6J Mice vol.20, pp.1, 2013, https://doi.org/10.1089/jmf.2016.3811
- First Report of Rust Caused by Coleosporium asterum on Aster spathulifolius in Korea vol.101, pp.11, 2017, https://doi.org/10.1094/pdis-12-16-1713-pdn
- In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus vol.51, pp.6, 2017, https://doi.org/10.1134/s0026893317060024
- Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies vol.22, pp.1, 2017, https://doi.org/10.1177/2156587216641831
- Germacrone inhibits adipogenesis and stimulates lipolysis via the AMP-activated protein kinase signalling pathway in 3T3-L1 preadipocytes vol.69, pp.2, 2017, https://doi.org/10.1111/jphp.12674
- Antiviral activity of five Asian medicinal pant crude extracts against highly pathogenic H5N1 avian influenza virus vol.10, pp.9, 2017, https://doi.org/10.1016/j.apjtm.2017.08.010
- Herbal Medicines with Antiviral Activity Against the Influenza Virus, a Systematic Review vol.46, pp.8, 2013, https://doi.org/10.1142/s0192415x18500854
- First Report of Powdery Mildew Caused by Podosphaera astericola on Aster spathulifolius in Korea vol.102, pp.5, 2018, https://doi.org/10.1094/pdis-09-17-1436-pdn
- Effect and Tolerability of the Combined Plant Extract (PAC) in Treatment of Acne Vulgaris vol.8, pp.2, 2018, https://doi.org/10.4236/jcdsa.2018.82009
- Antiviral Activities of Oleanolic Acid and Its Analogues vol.23, pp.9, 2013, https://doi.org/10.3390/molecules23092300
- Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules vol.25, pp.21, 2013, https://doi.org/10.3390/molecules25214878